Dabigatran

Basic Information

Item Value
DrugBank ID DB14726
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 61

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 hemoglobinopathy KG + DL
2 myocardial infarction KG + DL
3 partial deletion of the short arm of chromosome 16 KG + DL
4 beta-thalassemia with other manifestations KG + DL
5 hemolytic anemia due to glucophosphate isomerase deficiency KG + DL
6 pyruvate kinase deficiency of red cells KG + DL
7 posterolateral myocardial infarction KG + DL
8 posteroinferior myocardial infarction KG + DL
9 septal myocardial infarction KG + DL
10 coronary thrombosis KG + DL
11 pyropoikilocytosis, hereditary KG + DL
12 rheumatoid arthritis KG + DL
13 myocardial infarction (disease) KG + DL
14 coronary stenosis KG + DL
15 thrombotic disease KG + DL
16 congenital coronary artery anomaly KG + DL
17 gout KG + DL
18 colobomatous microphthalmia-rhizomelic dysplasia syndrome KG + DL
19 postoperative ventricular dysfunction KG + DL
20 brachydactyly-syndactyly syndrome KG + DL
21 autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome KG + DL
22 brain small vessel disease 1 with or without ocular anomalies KG + DL
23 diabetic nephropathy KG + DL
24 pulmonary valve disease KG + DL
25 Jeune syndrome situs inversus KG + DL
26 interventricular septum aneurysm KG + DL
27 heart disease KG + DL
28 Pierre Robin syndrome associated with a chromosomal anomaly KG + DL
29 orofacial clefting syndrome KG + DL
30 partial deletion of the long arm of chromosome 7 KG + DL
31 bronchitis KG + DL
32 partial deletion of the long arm of chromosome 22 KG + DL
33 disorder of fucoglycosan synthesis KG + DL
34 genetic syndromic Pierre Robin syndrome KG + DL
35 Laubry-Pezzi syndrome KG + DL
36 Prinzmetal angina KG + DL
37 vein disease KG + DL
38 mitral valve disease KG + DL
39 heparin cofactor 2 deficiency KG + DL
40 cavernous sinus thrombosis KG + DL
41 lateral sinus thrombosis KG + DL
42 angiodysplasia KG + DL
43 venous thromboembolism KG + DL
44 fibrocartilaginous embolism KG + DL
45 myositis fibrosa KG + DL
46 idiopathic granulomatous myositis KG + DL
47 antithrombin deficiency type 2 KG + DL
48 factor 5 excess with spontaneous thrombosis KG + DL
49 non-inflammatory vasculopathy KG + DL
50 tendinitis KG + DL

(Showing top 50 of 61 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.